Five Important Questions About Pfizer’s COVID-19 Vaccine
The drugmaker says its mRNA vaccine worked in 90% of patients in its trial, but some observers question how long immunity will last and who will benefit.
http://dlvr.it/RlS8Lh
http://dlvr.it/RlS8Lh
Comments
Post a Comment